On March 7, 2016, International Stem Cell Corporation (OTCQB: ISCO) announced that the Melbourne Health Human Research Ethics Committee (HREC) had approved its application to initiate phase I clinical trials of ISC-hpNSC® (human parthenogenetic neural stem cells) for the treatment of moderate to severe Parkinson’s disease. With that approval, ISCO has begun enrolling patients for […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.